A novel electrochemical membrane bioreactor (EMBR) was developed for enhancing PPCPs removal from real municipal wastewater. Compared to the control MBR (CMBR) without applying electric field, EMBR exhibited higher removal efficiencies for 14 PPCPs among all investigated PPCPs, including 3 fluoroquinolones, 2 macrolides, 6 sulfonamides and 3 anti-inflammatory drugs, while no significant difference was observed for the rest 8 PPCPs. The enhanced removal of 14 PPCPs was mainly attributed to electrooxidation by the direct anodic oxidation and reactive oxygen species-mediated indirect oxidation. Moreover, membrane fouling rates of EMBR (0.55 ± 0.10 kPa/d) were significantly reduced compared with CMBR (0.99 ± 0.09 kPa/d). Microbial activities and community analyses demonstrated that the applied electric field had no noticeable adverse impact on microbial viabilities, richness and diversity. These findings demonstrated that this EMBR enhanced pollutant removal and mitigated membrane fouling simultaneously, highlighting the potential of the novel technology to be used for removing PPCPs from wastewater.
Keywords: Biological degradation; Electrochemical advanced oxidation; Membrane bioreactor; Pharmaceuticals and personal care products (PPCPs); Wastewater treatment.
Copyright © 2020 Elsevier Ltd. All rights reserved.